Gadre, Abhishek
Highland, Kristin B.
Article History
First Online: 8 October 2018
Compliance with Ethical Standards
:
: Abhishek Gadre declares no conflict of interest. Highland receives grants/contracts, does consulting, and/or is on the Speaker’s Bureau of Actelion Pharmaceuticals, Bayer Healthcare, Boehringer Ingelheim, Eiger Pharmaceuticals, Gilead Sciences, Reata Pharmaceuticals, and United Therapeutics. Dr. Highland is the global coordinating investigator for the SENSCIS trial (nintedanib versus placebo for scleroderma associated lung disease). She is also a consultant for Boehringer Ingelheim and is on their Speaker’s Bureau. She is also a consultant for Boehringer Ingelheim and is on their Speaker’s Bureau.
: This article does not contain any studies with human or animal subjects performed by any of the authors.